Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kelly Monroe"'
Autor:
William A Faubion, Rodney D Newberry, Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly Monroe, Billy D Nix
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Background Forty distinct primary sclerosing cholangitis (PSC) genomic loci have been identified through multiancestry meta-analyses. The polygenic risk score (PRS) could serve as a promising tool to discover unique disease behaviour, like PSC, under
Externí odkaz:
https://doaj.org/article/785e6c5034e74ee48c0a9aa92cccda9c
Autor:
Bana Jabri, Dustin Shaw, Raúl Aguirre-Gamboa, Marcos Vieria, Saideep Gona, Nicholas DiNardi, Anni Wang, Anne Dumaine, Jody Gederloos, Zachary Earley, Katherine Meckel, Cezary Ciszewski, Anabella Castillo, Kelly Monroe, Joana Torres, Shailja Shah, Jean-Frederic Colombel, Steven Itzkowitz, Rodney Newberry, Russell Cohen, David Rubin, Sarah Cobey, Iris H. Jonkers, Christopher Weber, Joel Pekow, Patrick Wilson, Luis Barreiro
Primary sclerosing cholangitis (PSC) is an autoimmune-like disease of the bile ducts that co-occurs with inflammatory bowel disease (IBD) in almost 90% of cases. Colorectal cancer is a major complication of patients with both PSC and IBD, and these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08e35467f666f176758174e816cd8fd7
https://doi.org/10.21203/rs.3.rs-1697242/v1
https://doi.org/10.21203/rs.3.rs-1697242/v1
Autor:
Kelly Monroe, Michael F. Picco, Kelly C. Cushing, Billy D. Nix, Laura E. Raffals, William A. Faubion, Ming-Hsi Wang, Rodney D. Newberry, Shabana F. Pasha, Jessica Friton, Jonathan A. Leighton
Publikováno v:
J Crohns Colitis
Background It is important to identify patients with inflammatory bowel disease [IBD] refractory to anti-tumour necrosis factor [TNF] therapy, to avoid potential adverse effects and to adopt different treatment strategies. We aimed to identify and va
Autor:
Kelly Monroe, Laura E. Raffals, Jessica Friton, Michael F. Picco, Rodney D. Newberry, William A. Faubion, Ming-Hsi Wang, Billy D. Nix, Jonathan A. Leighton, Shabana F. Pasha
Publikováno v:
Inflammatory bowel diseases. 27(12)
Background We aimed to identify a model of clinical and genetic risk factors through hypothesis-free search across genome that can predict the surgical recurrence risk after the first abdominal surgery in CD patients. Materials and Methods Two indepe
Autor:
Michael F. Picco, Kelly C. Cushing, Rodney D. Newberry, Jonathan A. Leighton, Omar Y. Mousa, William A. Faubion, Ming-Hsi Wang, Shabana F. Pasha, Billy D. Nix, Kelly Monroe, Jessica Friton, Laura E. Raffals
Publikováno v:
Inflamm Bowel Dis
Introduction Ulcerative colitis (UC) associated with primary sclerosing cholangitis (PSC) is a rare phenotype. We aimed to assess patients with UC-PSC or UC alone and describe differences in clinical and phenotypic characteristics, antitumor necrosis
Autor:
William A. Faubion, Ming-Hsi Wang, Laura H. Raffals, Michael F. Picco, Shabana F. Pasha, Jessica Friton, Rodney D. Newberry, Billy D. Nix, Kelly Monroe, Jonathan A. Leighton
Publikováno v:
Gastroenterology. 158:S-794
Autor:
Kimberly Kelly Monroe, Kerry Mychaliska, Olivia Negris, Cathy Lewis, Madeline Nowicki, Stephen Amori, Judy Schummer
Publikováno v:
Pediatrics. 141:404-404
Autor:
Kelly Monroe, Navya D. Kanuri, Joanna J. Gilbertsen, Alexandra Gutierrez, Matthew A. Ciorba, Neelendu Dey, Emily Vivio, Chien-Huan Chen
Publikováno v:
Journal of Crohn'scolitis. 10(4)
Background and aims: Vedolizumab inhibits leucocyte vascular adhesion and migration into the gastrointestinal tract through α4β7 integrin blockade. This agent became available in mid-2014 for the treatment of moderate to severe Crohn’s disease (C
Autor:
Kelly Monroe Kullberg, Lael Arrington
For those who want to love God with their hearts and minds, editors Kelly Monroe Kullberg and Lael Arrington weave together both inspiration and illumination throughout this collection of daily readings. Faith and Culture: A Guide to a Culture Shaped